Naratriptan is a triptan drug that is selective for the 5-hydroxytryptamine1 receptor subtype. It is typically used for the treatment of migraine headaches.
For the acute treatment of migraine attacks with or without aura in adults.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.